AIMEDBIO
IR
ENG
KOR
ABOUT US
Overview
Leadership
Corporate Governance
R&D
AimedBio’s Drug Development
P-ADC™
Pipeline
IR
Disclosure
Stock
Financial Information
PR
Notice
Press Release
Data Room
CAREERS
Our Culture
Recruitment Process
Job Opportunities
Disclosure
54 posts
NO.
Title
Date
Author
44
Annual Report (2025.12)
2026-03-19
에임드바이오
43
Submission of Audit Report
2026-03-19
에임드바이오
42
Report on status of specific securities, etc. owned by executives and major shareholders
2026-03-17
인터베스트
41
Report on significant holdings of stocks, etc. (Short form)
2026-03-17
인터베스트
40
Reference documents for proxy solicitation
2026-03-12
에임드바이오
39
Announcement of convocation of general meeting of shareholders
2026-03-12
에임드바이오
38
Reporting reasons for holding general shareholders' meeting on the most concentrated date
2026-03-11
에임드바이오
37
Resolutions for Convocation of General Meeting of Shareholders
2026-03-11
에임드바이오
36
Notice on Investor Relations
2026-02-27
에임드바이오
35
Notice on Investor Relations
2026-02-27
에임드바이오
Annual Report (2025.12)
에임드바이오
2026-03-19
Submission of Audit Report
에임드바이오
2026-03-19
Report on status of specific securities, etc. owned by executives and major shareholders
인터베스트
2026-03-17
Report on significant holdings of stocks, etc. (Short form)
인터베스트
2026-03-17
Reference documents for proxy solicitation
에임드바이오
2026-03-12
Announcement of convocation of general meeting of shareholders
에임드바이오
2026-03-12
Reporting reasons for holding general shareholders' meeting on the most concentrated date
에임드바이오
2026-03-11
Resolutions for Convocation of General Meeting of Shareholders
에임드바이오
2026-03-11
Notice on Investor Relations
에임드바이오
2026-02-27
Notice on Investor Relations
에임드바이오
2026-02-27
1
2
3
4
5